IM­brave150: Roche’s reg­u­la­to­ry crew plans a glob­al roll­out of Tecen­triq com­bo for liv­er can­cer as PhI­II scores a hit

Just weeks af­ter Bris­tol-My­ers Squibb de­fend­ed its failed piv­otal study pit­ting Op­di­vo against Nex­avar in liv­er can­cer, Roche says it’s beat the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.